Business Context and Reporting Period
This Form 8-K was filed by cbdMD, Inc. on March 8, 2021, reporting an event that occurred on the same date. The company is an emerging growth company incorporated in North Carolina, with its principal executive offices in Charlotte, NC. The filing addresses unregistered sales of equity securities related to a prior merger agreement.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics for the current period. The only specific financial figure disclosed is the net revenue used to calculate earnout shares:
- Net Revenue (Second Marking Period ending Dec 31, 2020): $44,063,801
Material Changes
The primary material change reported is the issuance of additional common stock pursuant to earnout rights established in a 2018 Merger Agreement with Cure Based Development, LLC.
- Event: Board approval of the issuance of 3,348,520 Earnout Shares.
- Trigger: Satisfaction of aggregate net revenue criteria for the second marking period (ending December 31, 2020).
- Recipients: Members of CBD Holding, LLC, including affiliates of executive officers Martin A. Sumichrast and R. Scott Coffman.
- Remaining Earnout Rights: 6,773,953 shares remain available for future issuance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the transaction.
- Regulatory Status: The issuance was exempt from registration under Section 4(a)(2) of the Securities Act of 1933 as the recipients were accredited investors.
- Unusual Items: The issuance represents a dilution event tied to historical performance milestones rather than a new capital raise or operational shift.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to assess dilution impact.
- Confirm the specific net revenue thresholds required for the remaining 6,773,953 Earnout Shares.
- Review the full Merger Agreement to understand the remaining 60-month timeline for earnout eligibility.
- Check subsequent filings for the actual issuance date and registration statement (if any) for these shares.